Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical eczema-like skin symptoms and joint swelling in a patient with Toxocara seropositivity - Case Report.

Annals of agricultural and environmental medicine : AAEM·2026
Same author

Selective biological activity of parthenolide derivatives - stizolin, stizolicin, and izospiciformin - isolated from the leaves of <i>Stizolophus balsamita</i>, in different breast cancer molecular subtypes <i>in vitro</i>.

Frontiers in pharmacology·2026
Same author

Antibiotic therapy in adult patients with infectious mononucleosis in the prehospital period - a single-center experience.

Otolaryngologia polska = The Polish otolaryngology·2026
Same author

An atypical case of infection with the Mpox virus clade IIb lineage C.1 - clinical and virological findings.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

The Challenges of Postoperative Tissue Flap Vitality Monitoring in Obese Individuals.

Journal of clinical medicine·2025
Same author

Toxocarosis, toxoplasmosis and ocular dirofilariasis diagnosed in a polish farmer from Wielkopolska Voivodeship - a case description.

BMC ophthalmology·2025

Related Experiment Video

Updated: May 28, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

NK cells prevalence, subsets and function in viral hepatitis C.

Jan Zeromski1, Iwona Mozer-Lisewska, Mariusz Kaczmarek

  • 1Chair and Department of Clinical Immunology, University of Medical Sciences, Rokietnicka 5D, 60-806, Poznan, Poland. jzeromski@ump.edu.pl

Archivum Immunologiae Et Therapiae Experimentalis
|October 6, 2011
PubMed
Summary
This summary is machine-generated.

Natural killer (NK) cells are crucial in fighting hepatitis C virus (HCV) infection, especially during the acute phase. However, their function is impaired in chronic HCV, contributing to liver injury, though therapy can partially restore their activity.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Experiment Videos

Last Updated: May 28, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Innate immunity, particularly natural killer (NK) cells, is implicated in the pathogenesis of hepatitis C virus (HCV) infection.
  • NK cells are abundant in the liver, possess cytotoxic potential, and interact with adaptive immunity, playing a key role in viral infections.

Purpose of the Study:

  • To investigate the role and function of NK cells in different phases of HCV infection.
  • To explore the impact of NK cell receptor polymorphisms on HCV prognosis.
  • To understand how HCV peptides affect NK cell activity and the potential for therapeutic reversal.

Main Methods:

  • Analysis of NK cell prevalence, cytotoxicity, and receptor expression in acute and chronic HCV.
  • Assessment of interferon-gamma secretion by NK cells.
  • Investigation of NK cell polarization and cytokine profiles.
  • Evaluation of HCV peptide effects on NK cell function and response to antiviral therapy.

Main Results:

  • Increased NK cell prevalence and cytotoxicity in acute HCV, with down-regulated inhibitory and up-regulated activating receptors.
  • Homozygosity for KIR2DL3/HLA-C1 predicts good prognosis in HCV infection.
  • Impaired NK cell prevalence and function in chronic HCV, with a shift towards NK2 polarization and secretion of immunosuppressive cytokines.
  • HCV peptides inhibit NK cell antiviral activity, an effect partially reversible by therapy.

Conclusions:

  • NK cells play a dual role in HCV infection, contributing to viral clearance in the acute phase and liver injury in the chronic phase.
  • NK cell receptor status and function are critical determinants of HCV disease progression and treatment response.
  • Targeting NK cell dysfunction represents a potential therapeutic strategy for chronic hepatitis C.